|
Market Closed -
Euronext Bruxelles
19:55:00 28/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 212.50 EUR | -0.89% |
|
+0.19% | -10.94% |
| 09-24 | BofA Reaffirms UCB at Buy Amid 'Very Confident' Outlook for Psoriasis Drug | MT |
| 09-24 | BofA Securities Keeps UCB at Buy | MT |
ETFs positioned on UCB
| Name | YTD change | Weight | AuM | |
|---|---|---|---|---|
 | +7.12% | -.--% | 6,576 M€ | |
| +15.67% | -.--% | 750 M€ | |
| +12.30% | -.--% | 13 M€ | |
| +0.69% | -.--% | 51 M€ | |
| +10.01% | -.--% | 66 M€ | |
| +6.60% | -.--% | 75 M€ | |
| +14.67% | -.--% | 4,105 M€ | |
| +8.92% | -.--% | 274 M€ | |
| +13.84% | -.--% | 298 M€ | |
| +9.09% | -.--% | 6 M€ | |
| -.--% | -.--% | 1,683 M€ | |
| +12.95% | -.--% | 1,674 M€ | |
| +6.62% | -.--% | 1,193 M€ | |
| +13.47% | 13.82% | 85 M€ | |
| +9.21% | 9% | 162 M€ | |
| +19.95% | 4.37% | 49 M€ | |
| +2.84% | 4.19% | 94 M€ | |
| -0.53% | 2.41% | 391 M€ | |
| +22.22% | 2.2% | 1,260 M€ | |
| -0.49% | 1.85% | 1,024 M€ | |
| +6.20% | 1.85% | 9 M€ | |
| +3.53% | 1.79% | 25 M€ | |
| -2.39% | 1.75% | 820 M€ | |
| +8.58% | 1.69% | 31 M€ | |
| +13.59% | 1.69% | 31 M€ | |
| +11.81% | 1.49% | 18 M€ | |
| +10.06% | 1.45% | 490 M€ | |
| +9.74% | 1.45% | 3,283 M€ | |
| +12.59% | 1.34% | 160 M€ | |
| +4.61% | 1.3% | 64 M€ | |
| +13.57% | 1.28% | 173 M€ | |
| +14.59% | 1.19% | 757 M€ | |
| +9.99% | 1.18% | 17 M€ | |
| +15.16% | 1.17% | 13 M€ | |
| +4.71% | 1.13% | 22 M€ | |
| +8.91% | 1.13% | 16 M€ |
Employees
9,000
Sector
Pharmaceuticals
Calendar
- Stock Market
- Stocks
- UCB Stock
- ETFs UCB
Select your edition
All financial news and data tailored to specific country editions
